IA Trial Radar | ||
|---|---|---|
L'essai clinique NCT06109844 pour Ulcère veineux de la jambe, Cicatrisation des plaies, Plaie non cicatrisante, Cytokines est en recrutement. Consultez la vue en carte du Radar des Essais Cliniques et les outils de découverte par IA pour tous les détails, ou posez vos questions ici. | ||
Un essai clinique correspond aux filtres sélectionnés
Vue en carte
FORCEREPAIR - A Wound Exudate Investigation
Les détails de l'essai clinique sont principalement disponibles en anglais. Cependant, l'IA Trial Radar peut vous aider ! Cliquez simplement sur 'Expliquer l'essai' pour voir et discuter des informations sur l'essai dans la langue sélectionnée.
L'étude clinique NCT06109844 est un essai observationnel pour Ulcère veineux de la jambe, Cicatrisation des plaies, Plaie non cicatrisante, Cytokines. Son statut actuel est : en recrutement. L'étude a débuté le 24 janvier 2024 et vise à recruter 20 participants. Dirigé par Bispebjerg Hospital, l'essai devrait être terminé d'ici le 30 juin 2025. Les données du site ClinicalTrials.gov ont été mises à jour pour la dernière fois le 9 juillet 2024.
Résumé succinct
The observational longitudinal study will collect wound exudate from twenty patients with venous leg ulcers. Wound exudate samples are collected using twenty-four-hour collection with polyurethane foam, bandages and the NovaSwab method. Each patient is seen four times where wound exudate and the bacteria microbiome are sampled and wound size is monitored with advanced planimetric tools.
Description détaillée
This dual centre longitudinal observational study will run from January 2024 to January 2025. The investigation will include twenty patients over four weeks including four study visits. Sampling of wound exudate can take place on every visit and will be made with the polyurethane discs, the NovaSwab technique and waste bandages. The wound bacteria microbiome is sampled with routine bacterial swabs. Tape strips will be used to assess perilesional skin and control sites of normal skin and will primarily measure skin inflammation parameters. Clinical pictures are taken and analysed using advanced planimetric tools. Patients enrolled receive standard wound care; allowing all kinds of dressing. However when consenting to twenty-four-hour-collection patients will not be allowed to wear active bandages or receive antibiotic treatment for that period. Compression, wound dressings, and use of topical and oral antibiotics will be registered. For the storage of samples, a research biobank is used, and leftover material will be stored in a biobank for future research.
Titre officiel
FORCEREPAIR - A Wound Exudate Investigation
Conditions
Ulcère veineux de la jambeCicatrisation des plaiesPlaie non cicatrisanteCytokinesPublications
Articles scientifiques et travaux de recherche publiés sur cet essai clinique:- Wolff-Winiski, Barbara, Anton Stütz, and Petra Dörfler. "Methods for identifying a non-healing skin wound and for monitoring the healing of a skin wound." U.S. Patent 11,579,141, issued February 14, 2023
- Burian EA, Sabah L, Karlsmark T, Kirketerp-Moller K, Moffatt CJ, Thyssen JP, Agren MS. Cytokines and Venous Leg Ulcer Healing-A Systematic Review. Int J Mol Sci. 2022 Jun 10;23(12):6526. doi: 10.3390/ijms23126526.
- Serra R, Grande R, Buffone G, Molinari V, Perri P, Perri A, Amato B, Colosimo M, de Franciscis S. Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines. Int Wound J. 2016 Feb;13(1):53-8. doi: 10.1111/iwj.12225. Epub 2014 Feb 19.
- Tomic-Canic M, Burgess JL, O'Neill KE, Strbo N, Pastar I. Skin Microbiota and its Interplay with Wound Healing. Am J Clin Dermatol. 2020 Sep;21(Suppl 1):36-43. doi: 10.1007/s40257-020-00536-w.
- Versey Z, da Cruz Nizer WS, Russell E, Zigic S, DeZeeuw KG, Marek JE, Overhage J, Cassol E. Biofilm-Innate Immune Interface: Contribution to Chronic Wound Formation. Front Immunol. 2021 Apr 9;12:648554. doi: 10.3389/fimmu.2021.648554. eCollection 2021.
- Misic AM, Gardner SE, Grice EA. The Wound Microbiome: Modern Approaches to Examining the Role of Microorganisms in Impaired Chronic Wound Healing. Adv Wound Care (New Rochelle). 2014 Jul 1;3(7):502-510. doi: 10.1089/wound.2012.0397.
- Wolcott RD, Hanson JD, Rees EJ, Koenig LD, Phillips CD, Wolcott RA, Cox SB, White JS. Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing. Wound Repair Regen. 2016 Jan-Feb;24(1):163-74. doi: 10.1111/wrr.12370. Epub 2015 Dec 10.
- Loesche M, Gardner SE, Kalan L, Horwinski J, Zheng Q, Hodkinson BP, Tyldsley AS, Franciscus CL, Hillis SL, Mehta S, Margolis DJ, Grice EA. Temporal Stability in Chronic Wound Microbiota Is Associated With Poor Healing. J Invest Dermatol. 2017 Jan;137(1):237-244. doi: 10.1016/j.jid.2016.08.009. Epub 2016 Aug 24.
- Trengove NJ, Bielefeldt-Ohmann H, Stacey MC. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen. 2000 Jan-Feb;8(1):13-25. doi: 10.1046/j.1524-475x.2000.00013.x.
- Wiegand C, Bittenger K, Galiano RD, Driver VR, Gibbons GW. Does noncontact low-frequency ultrasound therapy contribute to wound healing at the molecular level? Wound Repair Regen. 2017 Sep;25(5):871-882. doi: 10.1111/wrr.12595. Epub 2017 Dec 8.
- Ambrosch A, Lobmann R, Pott A, Preissler J. Interleukin-6 concentrations in wound fluids rather than serological markers are useful in assessing bacterial triggers of ulcer inflammation. Int Wound J. 2008 Mar;5(1):99-106. doi: 10.1111/j.1742-481X.2007.00347.x. Epub 2008 Jan 3.
- Burian EA, Enevold C, Karlsmark T, Agren MS. A simplified method for monitoring cytokines in wound fluid. Wound Repair Regen. 2023 Jan;31(1):47-55. doi: 10.1111/wrr.13053. Epub 2022 Oct 26.
Autres identifiants de l'essai
- FORCEREPAIR-01
- 104834 (Identifiant de registre) (Research Ethics Comittee)
Numéro NCT
Date de début (réel)
2024-01-24
Dernière mise à jour publiée
2024-07-09
Date de fin (estimée)
2025-06-30
Inscription (estimée)
20
Type d'essai
Observationnel
Statut
En recrutement
Mots clés
Venous Leg Ulcer
Varicose Ulcer
Cytokines
Wound Exudate
Wound Healing
Wound Inflammation
Wound Microbiome
Varicose Ulcer
Cytokines
Wound Exudate
Wound Healing
Wound Inflammation
Wound Microbiome
Bras / Interventions
| Groupe de participants/Bras | Intervention/Traitement |
|---|---|
N/A | Standard de soins Patients enrolled in this observational study receive standard of care. Treatment, ointments, compression and bandages will be registered at every visit. |
Critère principal d'évaluation
Critère secondaire d'évaluation
| Critères d'évaluation | Description de critères | Période |
|---|---|---|
Wound Exudate Effects on Proliferation of Healthy Primary Human Fibroblasts | Proliferation | Four weeks |
Wound Exudate Effects on Matrix Formation by Healthy Primary Human Fibroblasts | Matrix Formation | Four weeks |
Wound Exudate Effects on Release of Pro-inflammatory Mediators | Release of pro-inflammatory Mediators | Four weeks |
Wound Exudate Effects on Cellular Gene Expression Profiles In Healthy Primary Human Fibroblasts | Gene Expression Profiles | Four weeks |
Exploratory Wound Exudate Compound and Device Testing | Wound Exudate Compounds | Four weeks |
| Critères d'évaluation | Description de critères | Période |
|---|---|---|
Wound Exudate Profile Relation to Percentage Area Reduction | Four Weeks | |
Wound Exudate Profile Relation to Wound Microbiome Profile | Four Weeks | |
Percentage Area Reduction Relation to Wound Microbiome Profile | Four Weeks | |
Comparisson of Wound Exudate Sampling Techniques | Polyurethane disc twenty-four-hour sampling, Bandages and NovaSwabs | Four Weeks |
Wound Microbiome 16 rRNA/18sRNA | Bioburden, Diversity and Pathogens | Four Weeks |
Wound Perilesional Skin Inflammation | Tape Strips from perilesional skin and control site. | Four Weeks |
Critères d'éligibilité
Âges éligibles
Adulte, Adulte âgé
Âge minimum
18 Years
Sexes éligibles
Tous
- Adults fulfilling all inclusion criteria
- Age >18 years
- Venous leg ulcer diagnosis and classic characteristics (localisation, varicose veins, brown-orange hyperpigmentation, leg oedema, stasis dermatitis, atrophie blanche or lipodermatosclerosis) verified by a wound expert (if in doubt venous doppler will be used for verification)
- Wound Area equal to or above 1 cm2 (measured with a ruler length x width)
- Patient can understand Danish
- Patient can comply with protocol
- Patient is fully informed about the study and has given informed consent
- Venous leg ulcer with communication to bone
- Known or suspected cancer in the wound
- Allergies towards products used in the study, e.g. polyurethane foam and tegaderm
- Dementia
- Judgement by the investigator that the patient is not suited for study participation
Akribes Biomedical GmbH
Vascular Research Unit and Department of Vascular Surgery
Partie responsable de l'essai
Frederik Plum, Investigateur principal, MD, Ph.D Fellow at University of Copenhagen, Bispebjerg Hospital
Contact central de l'essai
Contact: Frederik Plum, MD, +4529671247, [email protected]
Contact: Klaus Kirketerp-Møller, MD, Ph.D, +4540199087, [email protected]
2 Centres de l'essai dans 1 pays
Northwest
Danish Wound Healing Center, Bispebjerg Hospital, Copenhagen, Northwest, 2400, Denmark
Frederik Plum, MD, Contact, +4529671247, [email protected]
Klaus Kirketerp-Møller, Consultant, Contact, +4540199087, [email protected]
Frederik Plum, MD, Investigateur principal
En recrutement
Vascular Research Unit and Department of Vascular Surgery, Viborg Regional Hospital, Viborg, 8800, Denmark
Annette Høgh, MD, Contact, [email protected]
En recrutement